Chemotherapy With or Without Preventive Anticoagulation for Metastatic Cancer of the Pancreas

Trial Profile

Chemotherapy With or Without Preventive Anticoagulation for Metastatic Cancer of the Pancreas

Discontinued
Phase of Trial: Phase III

Latest Information Update: 12 Mar 2013

At a glance

  • Drugs Dalteparin sodium (Primary) ; Capecitabine; Gemcitabine
  • Indications Pancreatic cancer; Thromboembolism
  • Focus Biomarker; Therapeutic Use
  • Acronyms PAM07
  • Most Recent Events

    • 19 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top